| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.0052 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0022 | 1 |